These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21143904)

  • 1. Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older.
    Yamazaki H; Yoshida K; Kotsuma T; Yoshioka Y; Koizumi M; Furukawa S; Kakimoto N; Shimizutani K; Nishimura T
    Radiat Oncol; 2010 Dec; 5():116. PubMed ID: 21143904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer.
    Kakimoto N; Inoue T; Inoue T; Murakami S; Furukawa S; Yoshida K; Yoshioka Y; Yamazaki H; Tanaka E; Shimizutani K
    Radiother Oncol; 2003 Aug; 68(2):123-8. PubMed ID: 12972306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose rate brachytherapy for early stage oral tongue cancer.
    Leung TW; Wong VY; Kwan KH; Ng TY; Wong CM; Tung SY; Leung LC; O SK
    Head Neck; 2002 Mar; 24(3):274-81. PubMed ID: 11891960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma.
    Santos MA; Guinot JL; Tortajada MI; Santamaría P; Campo V; Oliver L; Peña M; Arribas L
    Brachytherapy; 2017; 16(6):1213-1218. PubMed ID: 28807749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
    Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio.
    Lau HY; Hay JH; Flores AD; Threlfall WJ
    Radiother Oncol; 1996 Apr; 39(1):15-8. PubMed ID: 8735489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brachytherapy for tongue cancer in the very elderly is an alternative to external beam radiation.
    Khalilur R; Hayashi K; Shibuya H
    Br J Radiol; 2011 Aug; 84(1004):747-9. PubMed ID: 20682593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer: influence of age on outcome.
    Yamazaki H; Inoue T; Yoshida K; Yoshioka Y; Furukawa S; Kakimoto N; Shimizutani K
    Anticancer Res; 2007; 27(1B):491-7. PubMed ID: 17348432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers.
    Gibbs IC; Le QT; Shah RD; Terris DJ; Fee WE; Goffinet DR
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):489-94. PubMed ID: 12957261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachytherapy for early oral tongue cancer: low dose rate to high dose rate.
    Yamazaki H; Inoue T; Yoshida K; Yoshioka Y; Furukawa S; Kakimoto N; Shimizutani K; Inoue T
    J Radiat Res; 2003 Mar; 44(1):37-40. PubMed ID: 12841597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base.
    Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM
    Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical results of N0 tongue cancer treated with interstitial brachytherapy and management of occult cervical node metastases].
    Tsujino K; Oshitani T; Kushima T; Mieda C; Hirota S; Ogawa K; Maruta T; Ikeda Y; Ueda E; Suematsu T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Jun; 51(6):671-7. PubMed ID: 1886756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age on the results of brachytherapy for early tongue cancer.
    Yamazaki H; Inoue T; Yoshida K; Imai A; Yoshioka Y; Tanaka E; Shimamoto S; Nakamura S; Inoue T; Nakamura H; Furukawa S; Shimizutani K
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):931-6. PubMed ID: 11240233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of boost technique (external beam radiotherapy or brachytherapy) on the outcome of patients with carcinoma of the base of the tongue.
    Regueiro CA; Millán I; de la Torre A; Valcárcel FJ; Magallón R; Fernández E; Aragón G
    Acta Oncol; 1995; 34(2):225-33. PubMed ID: 7718261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue.
    Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Ishii J; Komori T
    Int J Oral Maxillofac Surg; 2005 Oct; 34(7):739-44. PubMed ID: 15921890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis.
    Takácsi-Nagy Z; Oberna F; Polgár C; Somogyi A; Major T; Németh G
    Neoplasma; 2001; 48(1):76-81. PubMed ID: 11327543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of treatment time on outcome of radiotherapy for oral tongue carcinoma.
    Hosokawa Y; Shirato H; Nishioka T; Tsuchiya K; Chang TC; Kagei K; Ohomori K; Obinata K; Kaneko M; Miyasaka K; Nakamura M
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):71-8. PubMed ID: 12909217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
    Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue.
    Harrison LB; Zelefsky MJ; Pfister DG; Carper E; Raben A; Kraus DH; Strong EW; Rao A; Thaler H; Polyak T; Portenoy R
    Head Neck; 1997 May; 19(3):169-75. PubMed ID: 9142514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative interstitial brachytherapy for resectable squamous cell carcinoma of the tongue.
    Goineau A; Piot B; Malard O; Ferron C; Lisbona A; Cassagnau E; Delamazure AS; Campion L; Bardet E
    Brachytherapy; 2015; 14(1):71-6. PubMed ID: 25454575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.